PMVP / PMV Pharmaceuticals, Inc. - Insider Trading and Ownership Report - SEC Form 3, 4, 5

PMV Pharmaceuticals, Inc.
US ˙ NasdaqGS ˙ US69353Y1038

Utestående aktier 52,990,864 shares
Insideraktier16 646 498 shares
Insynsägande31,41 %
Totalt antal insynspersoner44
Insider Sentiment Score

Insider sentiment score hittar de företag som köps av foretagsinsynspersoner.

Det är resultatet av en sofistikerad, kvantitativ multifaktormodell som identifierar företag med de högsta nivåerna av insiderackumulation. Poängmodellen använder en kombination av nettoantalet insiders som köpt de föregående 90 dagarna, det totala antalet aktier som köpts i procent av aktiekapitalet och det totala antalet aktier som ägs av insiders. Siffran sträcker sig från 0 till 100, med högre siffror som indikerar en högre nivå av ackumulering för sina kamrater, och 50 är genomsnittet.

Uppdateringsfrekvens: Dagligen

Se Insiders Top Picks, som ger en lista över företag med högsta insiderackumulation.

Se Högst rankade aktier
Office Sentiment Score

Officersentiment Score hittar företag som köps av Corporate Officers.

Per definition Corporate Officers är Corporate Insiders, men till skillnad från vissa av de andra Insiders (10 % aktieägare och styrelseledamöter), arbetar ämbetsmän för företaget dagligen och de använder sina egna pengar när de handlar . (10 % aktieägare och styrelseledamöter är ofta fondförvaltare som förvaltar andras pengar.) Som sådan är insideraffärer som görs av tjänstemän mycket mer betydelsefulla och bör behandlas på lämpligt sätt.

Liksom Insider Sentiment Score är Officer Sentiment Score resultatet av en sofistikerad, kvantitativ multifaktormodell som identifierar företag med de högsta nivåerna av officersackumulering.

Uppdateringsfrekvens: Dagligen

Se insiderns bästa val, vilket ger en lista över företag med högsta insider sentiment.

Se Högst rankade aktier
Viktiga insidernyckeltal

Denna kort visar hur företaget rankas längs olika insidernyckeltal. Procenttilrankningen visar hur detta företag jämförs med andra företag på USA-marknaden. Högre rankingar indikerar bättre situationer.

Till exempel anses det allmänt att insiderköp är en positiv indikator, så företag med mer insiderköp skulle rankas högre än företag med mindre insiderköp (eller til och med insiderförsäljning).

Nettoantalet insiders som köper (rankning)

-4 ( )

10876 out of 11305

Nettoantalet insiders som köper är den totala mängden insiders som säljer minus det totala antalet insiders som säljer under de senaste 90 dagarna. Percentilrankningen visas här (intervall från 0 till 100%).

Procent av flytande köpta av insiders (ranking)

-0.395 %( )

10898 out of 11224

Procentandelen av aktier köpta av insiders är det totala antalet aktier som köpts av insiders minus det totala antalet aktier som sålts av insiders under de senaste 90 dagarna, dividerat med det totala antalet aktier och multiplicerat med 100.

Insiderhandelsdiagram

PMV Pharmaceuticals, Inc. insideraffärer visas i följande diagram. Insiders är tjänstemän, styrelseledamöter eller betydande investerare i ett företag. I allmänhet är det i allmänhet olagligt för insiders att göra affärer i sina företag baserat på väsentlig, icke-offentlig information. Detta betyder inte att det är olagligt för dem att göra några affärer i sina egna företag. De måste dock rapportera alla affärer till SEC via ett formulär 4.

Insiderlista och lönsamhetsstatistik

Den här tabellen visar listan över kända insiders och genereras automatiskt från anmälningar som avslöjas till SEC. Förutom namnen, den senaste titeln och direktören, tjänstemannen eller ägarbeteckningen på 10 %, tillhandahåller vi de senaste avslöjade innehaven. Dessutom, när det är möjligt tillhandahåller vi insiderns historiska handelsresultat. Det historiska handelsresultatet är ett vägt genomsnitt av resultatet för faktiska köptransaktioner på den öppna marknaden som insidern gjort. För mer information om hur detta beräknas, titta på detta YouTube-webinarium.

See our leaderboard of most profitable insider traders.

Insider Genomsnitt vinst (%) Aktier
Ägda		 Delad
Justerad
Leila Alland Chief Medical Officer - [O] 45 909 45 909
Boxer Asset Management Inc. 10% Owner - [10%] 60 837 60 837
Boxer Capital, LLC - 60 837 60 837
Michael Carulli Chief Financial Officer - [O] 60 146 60 146
Ashvin Chhabra 10% Owner - [10%] 127 099 127 099
Davis Aaron I. 10% Owner - [10%] 60 837 60 837
Samantha Dawson 10% Owner - [10%] 427 342 427 342
Keval Desai 10% Owner - [10%] 25 552 25 552
Philippe Detournay 10% Owner - [10%] 2 528 290 2 528 290
Double Epiphany, LLC 10% Owner - [10%] 1 282 026 1 282 026
Euclidean Capital LLC 10% Owner - [10%] 127 099 127 099
Kirsten Flowers 32 677
Greenland A LLC 10% Owner - [10%] 127 099 127 099
Greenland FP LLC 10% Owner - [10%] 127 099 127 099
Insider Genomsnitt vinst (%) Aktier
Ägda		 Delad
Justerad
Greenland NFP B Ltd. 10% Owner - [10%] 127 099 127 099
Greenland NFP LLC 10% Owner - [10%] 127 099 127 099
Heyman Richard A. Director - [D] 0 0
Interwest Partners X Lp 10% Owner - [10%] 25 552 25 552
InterWest Management Partners X, LLC 10% Owner - [10%] 25 552 25 552
Deepika Jalota Chief Development Officer - [O] 89 959 89 959
Gilbert H Kliman 10% Owner - [10%] 25 552 25 552
Peter Kolchinsky 10% Owner - [10%] 1 710 265 1 710 265
Winston Kung COO, CFO - [O] 10 600 10 600
Arnold J Levine Director - [D] 409 842 409 842
Joseph Lewis 10% Owner - [10%] 60 837 60 837
Alison Levine 10% Owner - [10%] 427 342 427 342
MVA Investors, LLC 10% Owner - [10%] 60 837 60 837
David Henry Mack President and CEO, Director - [D] [O] 536 133 536 133
Khaled Nasr 10% Owner - [10%] 25 552 25 552
Insider Genomsnitt vinst (%) Aktier
Ägda		 Delad
Justerad
Nextech V Oncology S.C.S., SICAV-SIF - 2 528 290 2 528 290
Orbimed Advisors Llc 10% Owner - [10%] 0 0
Orbimed Capital Llc Director, 10% Owner - [D] [10%] 0 0
Arnold L Oronsky Director, 10% Owner - [D] [10%] 6 469 911 6 469 911
OrbiMed Capital GP V LLC Director, 10% Owner - [D] [10%] 475 000 0
OrbiMed Genesis GP LLC Director, 10% Owner - [D] [10%] 475 000 0
Ra Capital Management, Llc 10% Owner - [10%] 1 710 265 1 710 265
James H Simons 10% Owner - [10%] 127 099 127 099
Thilo Schroeder Director - [D] 1 101 283 1 101 283
Shah Rajeev M. 10% Owner - [10%] 1 710 265 1 710 265
Marilyn Simons 10% Owner - [10%] 127 099 127 099
Symmetry Group Ltd. 10% Owner - [10%] 127 099 127 099
Thompson Peter A. Director, 10% Owner - [D] [10%] 475 000 475 000
Robert Ticktin General Counsel & COO - [O] 98 695 98 695
Wellington Biomedical Innovation Master Investors (Cayman) I L.P. - 760 267 760 267

Report errors via our new Insider Auditing Tool

Track Records av insiderköp - Kortsiktig vinstanalys

I denna sektion analyserar vi lönsamheten för varje oplanerat, öppet-marknads insiderköp gjorda i PMVP / PMV Pharmaceuticals, Inc.. Denna analys hjälper till att förstå om insidern konsekvent genererar onormala avkastningar och är värd att följa. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .

Tabellen nedan visar de senaste köpen på öppna marknaden som inte var en del av en automatisk handelsplan.

Handelsdatum Insider Rapporterade
aktier		 Rapporterat
pris		 Justerade
aktier		 Justerat
pris		 Kostnadsbasis Dagar til
Max		 Pris vid
Max		 Maximal
vinst ($)		 Maximal avkastning (%)
2020-09-29 RA CAPITAL MANAGEMENT, LLC 950 000 18,0000 950 000 18,0000 17 100 000 93 61.51 41 334 500 241,72
2020-09-25 INTERWEST PARTNERS X LP 55 555 18,0000 55 555 18,0000 999 990
2020-09-25 ORBIMED ADVISORS LLC 475 000 18,0000 475 000 18,0000 8 550 000
2020-09-25 ORBIMED ADVISORS LLC 475 000 18,0000 475 000 18,0000 8 550 000
2020-09-25 Boxer Capital, LLC 950 000 18,0000 950 000 18,0000 17 100 000

Justeringar av aktierär de justerade aktierna efter justerat pris. Justeringar av aktierär de justerade aktierna efter uppdelning.

PMVP / PMV Pharmaceuticals, Inc. Insider Trades
Track Records av insiderförsäljning - Kortsiktig förlustanalys

I denna sektion analyserar vi lönsamheten för varje oplanerat, öppet-marknads insiderköp gjorda i PMVP / PMV Pharmaceuticals, Inc.. Denna analys hjälper till att förstå om insidern konsekvent genererar onormala avkastningar och är värd att följa. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .

Tabellen nedan visar de senaste försäljningarna på öppna marknaden som inte var en del av en automatisk handelsplan.

Handelsdatum Insider Rapporterade
aktier		 Rapporterat
pris		 Justerade
aktier		 Justerat
pris		 Kostnadsbasis Dagar til
Min		 Pris vid
Min		 Maximal förlust
undvikits ($)		 Maximal förlust
undvikits ($)
2025-07-01 Ticktin Robert 23 151 1,0648 23 151 1,0648 24 651 0 1.0500 −342 −1,39
2025-07-01 Mack David Henry 58 411 1,0645 58 411 1,0645 62 179
2025-07-01 Carulli Michael 28 249 1,0647 28 249 1,0647 30 077
2025-07-01 Jalota Deepika 33 065 1,0645 33 065 1,0645 35 198
2024-09-11 Jalota Deepika 7 218 1,5036 7 218 1,5036 10 853
2024-09-11 Carulli Michael 2 891 1,5036 2 891 1,5036 4 347
2023-11-22 ORBIMED ADVISORS LLC 87 786 2,2300 87 786 2,2300 195 763
2023-09-15 Alland Leila 6 291 6,6200 6 291 6,6200 41 646
2023-09-15 Jalota Deepika 4 104 6,6200 4 104 6,6200 27 168

Justeringar av aktierär de justerade aktierna efter justerat pris. Justeringar av aktierär de justerade aktierna efter uppdelning.

PMVP / PMV Pharmaceuticals, Inc. Insider Trades
Transaktionshistorik

Klicka på länkikonen för att se hela transaktionshistoriken. Transaktioner som rapporteras som en del av en automatisk handelsplan 10b5-1 kommer att ha ett X i kolumnen markerad 10b-5.

Fil
datum		 Handel
datum		 Schema Insider Ticker Värdepappertitel Kod 10b5-1 Direkta Utövningspris Enhet
pris		 Enheter
ändrad		 Värde
ändrad (1K)		 Kvarvarande
Optioner		 Kvarvarande
Aktier
2025-07-03 2025-07-01 4 Ticktin Robert PMVP Common Stock S - Sale D 1,0648 −23 151 −25 98 695
2025-07-03 2025-07-01 4 Jalota Deepika PMVP Common Stock S - Sale D 1,0645 −33 065 −35 89 959
2025-07-03 2025-07-01 4 Carulli Michael PMVP Common Stock S - Sale D 1,0647 −28 249 −30 60 146
2025-07-03 2025-07-01 4 Mack David Henry PMVP Common Stock S - Sale D 1,0645 −58 411 −62 536 133
2025-04-23 3 Ticktin Robert PMVP Common Stock D 106 318
2025-01-22 2025-01-03 4 Mack David Henry PMVP Common Stock M - Exercise D 0,5300 17 709 9 551 919
2025-01-22 2024-12-03 4 Mack David Henry PMVP Common Stock M - Exercise D 0,5300 91 750 49 534 210
2024-09-12 2024-09-11 4 Jalota Deepika PMVP Common Stock S - Sale D 1,5036 −7 218 −11 118 283
2024-09-12 2024-09-11 4 Carulli Michael PMVP Common Stock S - Sale D 1,5036 −2 891 −4 88 395
2024-01-22 2024-01-18 4 Jalota Deepika PMVP Common Stock A - Award D 95 555 125 501
2024-01-22 2024-01-18 4 Carulli Michael PMVP Common Stock A - Award D 82 220 91 286
2024-01-22 2024-01-18 4 Mack David Henry PMVP Common Stock A - Award D 163 890 442 460
2024-01-11 3 Carulli Michael PMVP Common Stock D 9 066
2023-11-24 2023-11-22 4 ORBIMED ADVISORS LLC See Footnotes PMVP Common Stock S - Sale I 2,2300 −87 786 −196 0
2023-11-13 2023-11-10 4 Mack David Henry PMVP Common Stock G - Gift I 85 307 165 307
2023-11-13 2023-11-10 4 Mack David Henry PMVP Common Stock G - Gift D −85 307 278 570
2023-11-13 2023-10-18 4 Mack David Henry PMVP Common Stock M - Exercise D 0,5300 198 407 105 363 877
2023-09-18 2023-09-15 4 Jalota Deepika PMVP Common Stock S - Sale D 6,6200 −4 104 −27 29 946
2023-09-18 2023-09-15 4 Alland Leila PMVP Common Stock S - Sale D 6,6200 −6 291 −42 45 909
2023-08-08 2023-08-07 4 Mack David Henry PMVP Common Stock M - Exercise D 0,5300 85 500 45 165 470
2023-01-30 2022-11-25 4 Kung Winston PMVP Common Stock G - Gift D −2 560 10 600
2022-09-13 2022-09-09 4 Jalota Deepika PMVP Common Stock A - Award D 34 050 34 050
2022-09-13 2022-09-09 4 Alland Leila PMVP Common Stock A - Award D 52 200 52 200
2022-05-31 2022-05-26 4 ORBIMED ADVISORS LLC See Footnotes PMVP Common Stock S - Sale I 15,9300 −26 253 −418 87 786
2022-04-29 2022-04-27 4 Mack David Henry PMVP Employee Stock Option (right to buy) M - Exercise D 0,53 −33 000 393 366
2022-04-29 2022-04-27 4 Mack David Henry PMVP Common Stock M - Exercise D 0,5300 33 000 17 79 970
2022-04-21 2022-04-20 4 Kung Winston PMVP Stock Option (right to buy) M - Exercise D 3,22 −4 000 210 034
2022-04-21 2022-04-20 4 Kung Winston PMVP Common Stock M - Exercise D 3,2200 4 000 13 10 600
2022-03-31 2022-03-31 4 ORBIMED ADVISORS LLC See Footnotes PMVP Common Stock S - Sale I 21,1700 −34 500 −730 0
2022-03-31 2022-03-30 4 ORBIMED ADVISORS LLC See Footnotes PMVP Common Stock S - Sale I 22,3900 −75 000 −1 679 34 500
2022-03-31 2022-03-29 4 ORBIMED ADVISORS LLC See Footnotes PMVP Common Stock S - Sale I 21,5200 −365 000 −7 855 109 500
2022-03-09 2022-03-08 4 Mack David Henry PMVP Stock Option (right to buy) M - Exercise D 1,37 −20 000 220 644
2022-03-09 2022-03-08 4 Mack David Henry PMVP Common Stock M - Exercise D 1,3700 20 000 27 46 970
2022-03-09 2021-03-09 4 Mack David Henry PMVP Common Stock G - Gift I 40 000 80 000
2022-03-09 2021-03-09 4 Mack David Henry PMVP Common Stock G - Gift I −40 000 147 915
2022-02-28 2022-02-10 4 Jalota Deepika PMVP Employee Stock Option (right to buy) A - Award D 16,29 68 100 68 100
2022-02-28 2022-02-10 4 Alland Leila PMVP Employee Stock Option (right to buy) A - Award D 16,29 104 400 104 400
2022-02-28 2022-02-10 4 Kung Winston PMVP Employee Stock Option (right to buy) A - Award D 16,29 104 400 104 400
2022-02-28 2022-02-10 4 Mack David Henry PMVP Employee Stock Option (right to buy) A - Award D 16,29 249 600 249 600
2022-02-08 2021-12-30 4 Kung Winston PMVP Common Stock G - Gift D −2 725 6 600
2022-01-10 2022-01-06 4 FLOWERS KIRSTEN PMVP Stock Option (right to buy) M - Exercise D 19,06 32 677 32 677
2021-12-16 2021-12-15 4 Mack David Henry PMVP Stock Option (right to buy) M - Exercise D 0,53 −9 000 432 574
2021-12-16 2021-12-15 4 Mack David Henry PMVP Common Stock M - Exercise D 0,5300 9 000 5 26 970
2021-12-16 2021-12-09 4 Mack David Henry PMVP Common Stock G - Gift I 40 000 40 000
2021-12-16 2021-12-09 4 Mack David Henry PMVP Common Stock G - Gift I −40 000 187 915
2021-10-08 2021-10-06 4 Schroeder Thilo PMVP Common Stock S - Sale I 30,1500 −800 −24 1 101 283
2021-10-04 2021-10-04 4 Schroeder Thilo PMVP Common Stock S - Sale I 30,0800 −100 −3 1 102 083
2021-10-04 2021-10-01 4 Schroeder Thilo PMVP Common Stock S - Sale I 30,1000 −11 541 −347 1 102 183
2021-10-04 2021-09-30 4 Schroeder Thilo PMVP Common Stock S - Sale I 30,0300 −2 978 −89 1 113 724
2021-09-29 2021-09-29 4 Schroeder Thilo PMVP Common Stock S - Sale I 30,0400 −5 708 −171 1 116 702
2021-09-29 2021-09-27 4 Schroeder Thilo PMVP Common Stock S - Sale I 30,1100 −1 753 −53 1 122 410
2021-09-24 2021-09-22 4 Schroeder Thilo PMVP Common Stock S - Sale I 30,0000 −100 −3 1 124 163
2021-09-23 2021-09-22 4 LEVINE ARNOLD J PMVP Common Stock S - Sale D 30,0000 −3 500 −105 409 842
2021-09-21 2021-09-17 4 Schroeder Thilo PMVP Common Stock S - Sale I 30,0300 −711 −21 1 124 263
2021-09-13 2021-09-13 4 Schroeder Thilo PMVP Common Stock S - Sale I 30,2000 −13 272 −401 1 124 974
2021-09-13 2021-09-10 4 Schroeder Thilo PMVP Common Stock S - Sale I 31,0300 −5 171 −160 1 138 246
2021-09-13 2021-09-10 4 Schroeder Thilo PMVP Common Stock S - Sale I 30,4400 −38 056 −1 158 1 143 417
2021-09-13 2021-09-09 4 Schroeder Thilo PMVP Common Stock S - Sale I 30,3100 −14 329 −434 1 181 473
2021-09-10 2021-09-09 4 Alland Leila PMVP Employee Stock Option (right to buy) M - Exercise D 3,90 −100 353 850
2021-09-10 2021-09-09 4 Alland Leila PMVP Common Stock S - Sale D 30,2500 −100 −3 0
2021-09-10 2021-09-09 4 Alland Leila PMVP Common Stock M - Exercise D 3,9000 100 0 100
2021-09-08 2021-09-07 4 Alland Leila PMVP Employee Stock Option (right to buy) M - Exercise D 3,90 −3 900 353 950
2021-09-08 2021-09-07 4 Alland Leila PMVP Common Stock S - Sale D 30,2500 −3 900 −118 0
2021-09-08 2021-09-07 4 Alland Leila PMVP Common Stock M - Exercise D 3,9000 3 900 15 3 900
2021-09-02 2021-09-02 4 Schroeder Thilo PMVP Common Stock S - Sale I 30,1500 −5 400 −163 1 195 802
2021-09-02 2021-09-01 4 Schroeder Thilo PMVP Common Stock S - Sale I 30,3800 −21 986 −668 1 201 202
2021-09-02 2021-08-31 4 Schroeder Thilo PMVP Common Stock S - Sale I 30,1200 −19 520 −588 1 223 188
2021-08-30 2021-08-30 4 Schroeder Thilo PMVP Common Stock S - Sale I 30,0500 −13 233 −398 1 242 708
2021-08-30 2021-08-27 4 Schroeder Thilo PMVP Common Stock S - Sale I 31,0600 −1 045 −32 1 255 941
2021-08-30 2021-08-27 4 Schroeder Thilo PMVP Common Stock S - Sale I 30,5000 −23 397 −714 1 256 986
2021-08-30 2021-08-26 4 Schroeder Thilo PMVP Common Stock S - Sale I 31,1300 −6 091 −190 1 280 383
2021-08-30 2021-08-26 4 Schroeder Thilo PMVP Common Stock S - Sale I 30,3900 −15 063 −458 1 286 474
2021-08-25 2021-08-25 4 Schroeder Thilo PMVP Common Stock S - Sale I 31,0100 −13 526 −419 1 585 953
2021-08-25 2021-08-24 4 Schroeder Thilo PMVP Common Stock S - Sale I 31,0800 −14 490 −450 1 599 479
2021-08-25 2021-08-23 4 Schroeder Thilo PMVP Common Stock S - Sale I 31,0600 −700 −22 1 613 969
2021-08-25 2021-08-23 4 Schroeder Thilo PMVP Common Stock S - Sale I 30,6600 −23 138 −709 1 614 669
2021-08-24 2021-08-23 4 LEVINE ARNOLD J PMVP Common Stock S - Sale D 29,5000 −3 500 −103 413 342
2021-08-20 2021-08-19 4 Schroeder Thilo PMVP Common Stock S - Sale I 30,9700 −3 800 −118 1 637 807
2021-08-20 2021-08-18 4 Schroeder Thilo PMVP Common Stock S - Sale I 34,3200 −2 237 −77 1 641 607
2021-08-20 2021-08-18 4 Schroeder Thilo PMVP Common Stock S - Sale I 33,8400 −13 196 −447 1 643 844
2021-08-20 2021-08-18 4 Schroeder Thilo PMVP Common Stock S - Sale I 32,5700 −11 431 −372 1 657 040
2021-08-20 2021-08-19 4 Mack David Henry PMVP Stock Option (right to buy) M - Exercise D 0,53 −5 500 441 574
2021-08-20 2021-08-19 4 Mack David Henry PMVP Common Stock M - Exercise D 0,5300 5 500 3 17 970
2021-08-20 2021-08-19 4 Kung Winston PMVP Stock Option (right to buy) M - Exercise D 3,22 −5 000 214 034
2021-08-20 2021-08-19 4 Kung Winston PMVP Common Stock M - Exercise D 3,2200 5 000 16 6 600
2021-08-18 2021-08-17 4 Jalota Deepika PMVP Stock option (right to buy) M - Exercise D 3,53 −2 896 87 320
2021-08-18 2021-08-17 4 Jalota Deepika PMVP Common Stock S - Sale D 33,7756 −2 896 −98 0
2021-08-18 2021-08-17 4 Jalota Deepika PMVP Common Stock M - Exercise D 3,5300 2 896 10 2 896
2021-08-17 2021-08-17 4 Schroeder Thilo PMVP Common Stock S - Sale I 33,9300 −15 746 −534 1 668 471
2021-08-17 2021-08-17 4 Schroeder Thilo PMVP Common Stock S - Sale I 33,2100 −15 276 −507 1 684 217
2021-08-17 2021-08-16 4 Schroeder Thilo PMVP Common Stock S - Sale I 34,5400 −2 599 −90 1 699 493
2021-08-17 2021-08-16 4 Schroeder Thilo PMVP Common Stock S - Sale I 33,8000 −19 584 −662 1 702 092
2021-08-17 2021-08-13 4 Schroeder Thilo PMVP Common Stock S - Sale I 34,6600 −1 500 −52 1 721 676
2021-08-17 2021-08-13 4 Schroeder Thilo PMVP Common Stock S - Sale I 34,2200 −25 786 −882 1 723 176
2021-08-12 2021-08-12 4 Schroeder Thilo PMVP Common Stock S - Sale I 34,8300 −1 971 −69 1 748 962
2021-08-12 2021-08-12 4 Schroeder Thilo PMVP Common Stock S - Sale I 34,3500 −11 565 −397 1 750 933
2021-08-12 2021-08-11 4 Schroeder Thilo PMVP Common Stock S - Sale I 34,0400 −34 439 −1 172 1 762 498
2021-08-12 2021-08-10 4 Schroeder Thilo PMVP Common Stock S - Sale I 35,5400 −2 600 −92 1 796 937
2021-08-12 2021-08-10 4 Schroeder Thilo PMVP Common Stock S - Sale I 34,7600 −17 905 −622 1 799 537
2021-08-10 2021-08-09 4 Alland Leila PMVP Employee Stock Option (right to buy) M - Exercise D 3,90 −4 000 357 850
2021-08-10 2021-08-09 4 Alland Leila PMVP Common Stock S - Sale D 36,6900 −224 −8 0
2021-08-10 2021-08-09 4 Alland Leila PMVP Common Stock S - Sale D 32,6567 −2 049 −67 224
2021-08-10 2021-08-09 4 Alland Leila PMVP Common Stock S - Sale D 35,0637 −2 198 −77 1 802
2021-08-10 2021-08-09 4 Alland Leila PMVP Common Stock M - Exercise D 3,9000 4 000 16 4 000
2021-08-09 2021-08-09 4 Schroeder Thilo PMVP Common Stock S - Sale I 36,6400 −300 −11 1 817 442
2021-08-09 2021-08-09 4 Schroeder Thilo PMVP Common Stock S - Sale I 36,0800 −8 623 −311 1 817 742
2021-08-09 2021-08-09 4 Schroeder Thilo PMVP Common Stock S - Sale I 35,1400 −13 259 −466 1 826 365
2021-08-09 2021-08-06 4 Schroeder Thilo PMVP Common Stock S - Sale I 36,9400 −200 −7 1 839 624
2021-08-09 2021-08-06 4 Schroeder Thilo PMVP Common Stock S - Sale I 36,6100 −19 700 −721 1 839 824
2021-08-09 2021-08-05 4 Schroeder Thilo PMVP Common Stock S - Sale I 36,7000 −8 740 −321 1 859 524
2021-08-09 2021-08-05 4 Schroeder Thilo PMVP Common Stock S - Sale I 36,3800 −26 871 −978 1 868 264
2021-08-04 2021-08-04 4 Schroeder Thilo PMVP Common Stock S - Sale I 36,8000 −5 249 −193 1 895 135
2021-08-04 2021-08-04 4 Schroeder Thilo PMVP Common Stock S - Sale I 36,2200 −28 676 −1 039 1 900 384
2021-08-04 2021-08-04 4 Schroeder Thilo PMVP Common Stock S - Sale I 35,1000 −17 175 −603 1 929 060
2021-08-04 2021-08-04 4 Schroeder Thilo PMVP Common Stock S - Sale I 34,2100 −1 760 −60 1 946 235
2021-08-04 2021-08-03 4 Schroeder Thilo PMVP Common Stock S - Sale I 34,7400 −100 −3 1 947 995
2021-08-04 2021-08-03 4 Schroeder Thilo PMVP Common Stock S - Sale I 33,8000 −30 145 −1 019 1 948 095
2021-08-04 2021-08-02 4 Schroeder Thilo PMVP Common Stock S - Sale I 34,7400 −13 031 −453 1 978 240
2021-08-04 2021-08-03 4 Kung Winston PMVP Stock Option (right to buy) M - Exercise D 3,22 −4 500 219 034
2021-08-04 2021-08-03 4 Kung Winston PMVP Common Stock S - Sale D 33,8173 −4 500 −152 1 600
2021-08-04 2021-08-03 4 Kung Winston PMVP Common Stock M - Exercise D 3,2200 4 500 14 6 100
2021-07-30 2021-07-29 4 Schroeder Thilo PMVP Common Stock S - Sale I 35,7300 −2 300 −82 1 991 271
2021-07-30 2021-07-28 4 Schroeder Thilo PMVP Common Stock S - Sale I 35,7600 −8 724 −312 1 993 571
2021-07-27 2021-07-27 4 Schroeder Thilo PMVP Common Stock S - Sale I 35,6100 −535 −19 2 002 295
2021-07-27 2021-07-26 4 Schroeder Thilo PMVP Common Stock S - Sale I 35,7300 −4 839 −173 2 002 830
2021-07-27 2021-07-23 4 Schroeder Thilo PMVP Common Stock S - Sale I 36,0000 −11 988 −432 2 007 669
2021-07-23 2021-07-22 4 Schroeder Thilo PMVP Common Stock S - Sale I 35,6100 −200 −7 2 019 657
2021-07-23 2021-07-21 4 Schroeder Thilo PMVP Common Stock S - Sale I 35,8200 −18 672 −669 2 019 857
2021-07-23 2021-05-12 4 Heyman Richard A. PMVP Stock Option (right to buy) A - Award D 28,33 5 781 5 781
2021-07-22 2021-07-20 4 LEVINE ARNOLD J PMVP Common Stock S - Sale D 35,1226 −3 500 −123 416 842
2021-07-22 2021-05-12 4 LEVINE ARNOLD J PMVP Stock Option (right to buy) A - Award D 28,33 5 781 5 781
2021-07-22 2021-07-21 4 Mack David Henry PMVP Stock Option (right to buy) M - Exercise D 0,53 −26 767 447 074
2021-07-22 2021-07-21 4 Mack David Henry PMVP Common Stock S - Sale D 35,7564 −26 767 −957 12 470
2021-07-22 2021-07-21 4 Mack David Henry PMVP Common Stock M - Exercise D 0,5300 26 767 14 39 237
2021-07-22 2021-07-20 4 Mack David Henry PMVP Stock Option (right to buy) M - Exercise D 0,53 −1 029 473 841
2021-07-22 2021-07-20 4 Mack David Henry PMVP Common Stock S - Sale D 35,5300 −1 029 −37 12 470
2021-07-22 2021-07-20 4 Mack David Henry PMVP Common Stock M - Exercise D 0,5300 1 029 1 13 499
2021-07-14 2021-07-13 4 INTERWEST PARTNERS X LP By Gilbert H. Kliman PMVP Common Stock J - Other I 22 148 25 552
2021-07-14 2021-07-13 4 INTERWEST PARTNERS X LP By: Keval Desai PMVP Common Stock J - Other I 2 441 2 816
2021-07-14 2021-07-13 4 INTERWEST PARTNERS X LP By: Khaled A. Nasr PMVP Common Stock J - Other I 3 642 4 201
2021-07-14 2021-07-13 4 INTERWEST PARTNERS X LP By: InterWest Management Partners X, LLC PMVP Common Stock J - Other I −97 632 0
2021-07-14 2021-07-13 4 INTERWEST PARTNERS X LP By: InterWest Management Partners X, LLC PMVP Common Stock J - Other I 97 632 97 632
2021-07-14 2021-07-13 4 INTERWEST PARTNERS X LP PMVP Common Stock J - Other D −500 000 4 469 911
2021-07-08 2021-07-08 4 Kung Winston PMVP Stock Option (right to buy) M - Exercise D 3,22 −4 500 223 534
2021-07-08 2021-07-08 4 Kung Winston PMVP Common Stock S - Sale D 33,7500 −4 500 −152 1 600
2021-07-08 2021-07-08 4 Kung Winston PMVP Common Stock M - Exercise D 3,2200 4 500 14 6 100
2021-07-08 2021-07-07 4 Alland Leila PMVP Employee Stock Option (right to buy) M - Exercise D 3,90 −4 000 361 850
2021-07-08 2021-07-07 4 Alland Leila PMVP Common Stock S - Sale D 32,6567 −2 049 −67 0
2021-07-08 2021-07-07 4 Alland Leila PMVP Common Stock S - Sale D 31,9321 −1 951 −62 2 049
2021-07-08 2021-07-07 4 Alland Leila PMVP Common Stock M - Exercise D 3,9000 4 000 16 4 000
2021-06-29 2021-06-28 4 Mack David Henry PMVP Stock Option (right to buy) M - Exercise D 0,53 −204 474 870
2021-06-29 2021-06-28 4 Mack David Henry PMVP Common Stock S - Sale D 35,5300 −204 −7 12 470
2021-06-29 2021-06-28 4 Mack David Henry PMVP Common Stock M - Exercise D 0,5300 204 0 12 674
2021-06-22 2021-06-21 4 LEVINE ARNOLD J PMVP Common Stock S - Sale D 34,0855 −111 −4 420 342
2021-06-22 2021-06-21 4 LEVINE ARNOLD J PMVP Common Stock S - Sale D 33,2189 −3 389 −113 420 453
2021-06-15 2021-06-14 4 Euclidean Capital LLC See Footnotes PMVP Common Stock S - Sale I 34,1100 −1 260 −43 127 099
2021-06-15 2021-06-14 4 Euclidean Capital LLC See Footnotes PMVP Common Stock S - Sale I 34,1100 −24 726 −843 2 496 554
2021-06-15 2021-06-14 4 Euclidean Capital LLC See Footnotes PMVP Common Stock S - Sale I 34,1100 −7 141 −244 720 999
2021-06-15 2021-06-14 4 Euclidean Capital LLC See Footnotes PMVP Common Stock S - Sale I 34,1100 −6 593 −225 665 696
2021-06-15 2021-06-14 4 Euclidean Capital LLC See Footnotes PMVP Common Stock S - Sale I 34,1100 −4 699 −160 474 363
2021-06-15 2021-06-11 4 Euclidean Capital LLC See Footnotes PMVP Common Stock S - Sale I 33,8000 −621 −21 128 359
2021-06-15 2021-06-11 4 Euclidean Capital LLC See Footnotes PMVP Common Stock S - Sale I 33,8000 −12 237 −414 2 521 280
2021-06-15 2021-06-11 4 Euclidean Capital LLC See Footnotes PMVP Common Stock S - Sale I 33,8000 −3 533 −119 728 140
2021-06-15 2021-06-11 4 Euclidean Capital LLC See Footnotes PMVP Common Stock S - Sale I 33,8000 −3 262 −110 672 289
2021-06-15 2021-06-11 4 Euclidean Capital LLC See Footnotes PMVP Common Stock S - Sale I 33,8000 −2 324 −79 479 062
2021-06-11 2021-06-10 4 Euclidean Capital LLC See Footnotes PMVP Common Stock S - Sale I 32,6800 −585 −19 129 980
2021-06-11 2021-06-10 4 Euclidean Capital LLC See Footnotes PMVP Common Stock S - Sale I 32,6800 −11 485 −375 2 533 517
2021-06-11 2021-06-10 4 Euclidean Capital LLC See Footnotes PMVP Common Stock S - Sale I 32,6800 −3 317 −108 731 673
2021-06-11 2021-06-10 4 Euclidean Capital LLC See Footnotes PMVP Common Stock S - Sale I 32,6800 −3 063 −100 675 551
2021-06-11 2021-06-10 4 Euclidean Capital LLC See Footnotes PMVP Common Stock S - Sale I 32,6800 −2 183 −71 481 386
2021-06-11 2021-06-09 4 Euclidean Capital LLC See Footnotes PMVP Common Stock S - Sale I 33,6400 −1 121 −38 129 565
2021-06-11 2021-06-09 4 Euclidean Capital LLC See Footnotes PMVP Common Stock S - Sale I 33,6400 −22 070 −742 2 545 002
2021-06-11 2021-06-09 4 Euclidean Capital LLC See Footnotes PMVP Common Stock S - Sale I 33,6400 −6 372 −214 734 990
2021-06-11 2021-06-09 4 Euclidean Capital LLC See Footnotes PMVP Common Stock S - Sale I 33,6400 −5 883 −198 678 614
2021-06-11 2021-06-09 4 Euclidean Capital LLC See Footnotes PMVP Common Stock S - Sale I 33,6400 −4 192 −141 483 569
2021-06-09 2021-06-08 4 Euclidean Capital LLC See Footnotes PMVP Common Stock S - Sale I 33,3800 −896 −30 130 686
2021-06-09 2021-06-08 4 Euclidean Capital LLC See Footnotes PMVP Common Stock S - Sale I 33,3800 −17 664 −590 2 567 072
2021-06-09 2021-06-08 4 Euclidean Capital LLC See Footnotes PMVP Common Stock S - Sale I 33,3800 −5 101 −170 741 362
2021-06-09 2021-06-08 4 Euclidean Capital LLC See Footnotes PMVP Common Stock S - Sale I 33,3800 −4 708 −157 684 497
2021-06-09 2021-06-08 4 Euclidean Capital LLC See Footnotes PMVP Common Stock S - Sale I 33,3800 −3 355 −112 487 761
2021-06-09 2021-06-07 4 Euclidean Capital LLC See Footnotes PMVP Common Stock S - Sale I 33,6200 −1 019 −34 131 582
2021-06-09 2021-06-07 4 Euclidean Capital LLC See Footnotes PMVP Common Stock S - Sale I 33,6200 −16 901 −568 2 584 736
2021-06-09 2021-06-07 4 Euclidean Capital LLC See Footnotes PMVP Common Stock S - Sale I 33,6200 −4 946 −166 746 463
2021-06-09 2021-06-07 4 Euclidean Capital LLC See Footnotes PMVP Common Stock S - Sale I 33,6200 −4 564 −153 689 205
2021-06-09 2021-06-07 4 Euclidean Capital LLC See Footnotes PMVP Common Stock S - Sale I 33,6200 −3 291 −111 491 116
2021-06-09 2022-06-02 4 Thompson Peter A. PMVP Stock option (right to buy) A - Award D 32,29 16 333 16 333
2021-06-09 2021-06-02 4 Stelzer Laurie PMVP Stock Option A - Award D 32,29 −16 333 16 333
2021-06-09 2021-06-02 4 LEVINE ARNOLD J PMVP Stock option (right to buy) A - Award D 32,29 16 333 16 333
2021-06-09 2021-06-02 4 Heyman Richard A. PMVP Stock Option (right to buy) A - Award D 32,29 16 333 16 333
2021-06-09 2021-06-02 4 BAUM CHARLES M PMVP Stock Option (right to buy) A - Award D 32,29 16 333 16 333
2021-06-08 2021-05-12 4 Jalota Deepika PMVP Employee Stock Option (right to buy) A - Award D 28,33 22 674 22 674
2021-06-08 2021-06-07 4 Alland Leila PMVP Employee Stock Option (right to buy) M - Exercise D 3,90 −4 000 365 850
2021-06-08 2021-06-07 4 Alland Leila PMVP Common Stock S - Sale D 34,0041 −1 367 −46 0
2021-06-08 2021-06-07 4 Alland Leila PMVP Common Stock S - Sale D 33,3852 −2 633 −88 1 367
2021-06-08 2021-06-07 4 Alland Leila PMVP Common Stock M - Exercise D 3,9000 4 000 16 4 000
2021-06-08 2021-05-12 4 Alland Leila PMVP Employee Stock Option (right to buy) A - Award D 28,33 36 279 36 279
2021-06-08 2021-05-12 4 Kung Winston PMVP Employee Stock Option (right to buy) A - Award D 28,33 50 337 50 337
2021-06-08 2021-05-12 4 Mack David Henry PMVP Employee Stock Option (right to buy) A - Award D 28,33 134 584 134 584
2021-06-07 2021-06-04 4 Kung Winston PMVP Stock Option (right to buy) M - Exercise D 3,22 −4 500 228 034
2021-06-07 2021-06-04 4 Kung Winston PMVP Common Stock S - Sale D 33,7500 −4 500 −152 1 600
2021-06-07 2021-06-04 4 Kung Winston PMVP Common Stock M - Exercise D 3,2200 4 500 14 6 100
2021-06-04 2021-05-21 4 Mack David Henry PMVP Stock Option (right to buy) M - Exercise D 0,53 −10 000 475 074
2021-06-04 2021-05-20 4 Mack David Henry PMVP Common Stock M - Exercise D 0,5300 10 000 5 12 470
2021-06-02 2021-05-28 4 Schroeder Thilo PMVP Common Stock S - Sale I 35,8000 −5 100 −183 2 038 529
2021-06-02 2021-06-01 4 Heyman Richard A. PMVP Stock Option (right to buy) M - Exercise I 2,95 −975 7 951
2021-06-02 2021-06-01 4 Heyman Richard A. PMVP Stock Option (right to buy) M - Exercise I 2,95 −975 7 951
2021-06-02 2021-06-01 4 Heyman Richard A. PMVP Stock Option (right to buy) M - Exercise I 2,95 −1 950 15 901
2021-06-02 2021-06-01 4 Heyman Richard A. PMVP Common Stock S - Sale I 34,6700 −2 −0 0
2021-06-02 2021-06-01 4 Heyman Richard A. PMVP Common Stock S - Sale I 34,6700 −2 −0 0
2021-06-02 2021-06-01 4 Heyman Richard A. PMVP Common Stock S - Sale I 33,7882 −209 −7 2
2021-06-02 2021-06-01 4 Heyman Richard A. PMVP Common Stock S - Sale I 32,1507 −764 −25 211
2021-06-02 2021-06-01 4 Heyman Richard A. PMVP Common Stock M - Exercise I 975,0000 975 951 975
2021-06-02 2021-06-01 4 Heyman Richard A. PMVP Common Stock S - Sale I 33,7465 −230 −8 2
2021-06-02 2021-06-01 4 Heyman Richard A. PMVP Common Stock S - Sale I 32,1618 −743 −24 232
2021-06-02 2021-06-01 4 Heyman Richard A. PMVP Common Stock M - Exercise I 2,9500 975 3 975
2021-06-02 2021-06-01 4 Heyman Richard A. PMVP Common Stock S - Sale I 34,6700 −5 −0 0
2021-06-02 2021-06-01 4 Heyman Richard A. PMVP Common Stock S - Sale I 33,6105 −553 −19 5
2021-06-02 2021-06-01 4 Heyman Richard A. PMVP Common Stock S - Sale I 32,1509 −1 392 −45 558
2021-06-02 2021-06-01 4 Heyman Richard A. PMVP Common Stock M - Exercise I 2,9500 1 950 6 1 950
2021-05-27 2021-05-26 4 Schroeder Thilo PMVP Common Stock S - Sale I 35,6600 −7 487 −267 2 043 629
2021-05-27 2021-05-25 4 Schroeder Thilo PMVP Common Stock S - Sale I 35,9100 −8 518 −306 2 051 116
2021-05-24 2021-05-24 4 Schroeder Thilo PMVP Common Stock S - Sale I 36,0300 −22 095 −796 2 059 634
2021-05-24 2021-05-21 4 Schroeder Thilo PMVP Common Stock S - Sale I 35,8400 −19 774 −709 2 081 729
2021-05-24 2021-05-20 4 Schroeder Thilo PMVP Common Stock S - Sale I 35,6500 −2 911 −104 2 101 503
2021-05-24 2021-05-21 4 Mack David Henry PMVP Stock Option (right to buy) M - Exercise D 0,53 −6 207 485 074
2021-05-24 2021-05-21 4 Mack David Henry PMVP Common Stock S - Sale D 35,7083 −6 207 −222 2 470
2021-05-24 2021-05-21 4 Mack David Henry PMVP Common Stock M - Exercise D 0,5300 6 207 3 8 677
2021-05-24 2021-05-20 4 Mack David Henry PMVP Stock Option (right to buy) M - Exercise D 0,53 −7 793 492 867
2021-05-24 2021-05-20 4 Mack David Henry PMVP Common Stock S - Sale D 35,6031 −7 793 −277 2 470
2021-05-24 2021-05-20 4 Mack David Henry PMVP Common Stock M - Exercise D 0,5300 7 793 4 10 263
2021-05-21 2021-05-20 4 LEVINE ARNOLD J PMVP Common Stock S - Sale D 34,6760 −2 961 −103 423 842
2021-05-21 2021-05-20 4 LEVINE ARNOLD J PMVP Common Stock S - Sale D 33,5664 −539 −18 426 803
2021-05-12 2021-05-10 4 Schroeder Thilo PMVP Common Stock S - Sale I 35,6700 −1 787 −64 2 104 414
2021-05-12 2021-05-10 4 INTERWEST PARTNERS X LP By Gilbert H. Kliman PMVP Common Stock J - Other I 1 135 3 404
2021-05-12 2021-05-10 4 INTERWEST PARTNERS X LP By: Keval Desai PMVP Common Stock J - Other I 125 375
2021-05-12 2021-05-10 4 INTERWEST PARTNERS X LP By: Khaled A. Nasr PMVP Common Stock J - Other I 186 559
2021-05-12 2021-05-10 4 INTERWEST PARTNERS X LP By: InterWest Management Partners X, LLC PMVP Common Stock J - Other I −5 000 0
2021-05-12 2021-05-10 4 INTERWEST PARTNERS X LP By: InterWest Management Partners X, LLC PMVP Common Stock J - Other I 5 000 5 000
2021-05-12 2021-05-10 4 INTERWEST PARTNERS X LP PMVP Common Stock J - Other D −500 000 4 969 911
2021-05-10 2021-05-07 4 Alland Leila PMVP Employee Stock Option (right to buy) M - Exercise D 3,90 −4 000 369 850
2021-05-10 2021-05-07 4 Alland Leila PMVP Common Stock S - Sale D 35,4891 −158 −6 0
2021-05-10 2021-05-07 4 Alland Leila PMVP Common Stock S - Sale D 34,8000 −3 842 −134 158
2021-05-10 2021-05-07 4 Alland Leila PMVP Common Stock M - Exercise D 3,9000 4 000 16 4 000
2021-05-07 2021-05-05 4 Schroeder Thilo PMVP Common Stock S - Sale I 35,6400 −600 −21 2 106 201
2021-05-07 3 SIMONS JAMES H See footnotes PMVP Common Stock I 132 601
2021-05-07 3 SIMONS JAMES H See footnotes PMVP Common Stock I 751 409
2021-05-07 3 SIMONS JAMES H See footnotes PMVP Common Stock I 2 601 637
2021-05-07 3 SIMONS JAMES H See footnotes PMVP Common Stock I 494 407
2021-05-07 3 SIMONS JAMES H See footnotes PMVP Common Stock I 693 769
2021-05-04 2021-05-03 4 Kung Winston PMVP Stock Option (right to buy) M - Exercise D 3,22 −4 500 232 534
2021-05-04 2021-05-03 4 Kung Winston PMVP Common Stock S - Sale D 33,7500 −4 500 −152 1 600
2021-05-04 2021-05-03 4 Kung Winston PMVP Common Stock M - Exercise D 3,2200 4 500 14 6 100
2021-04-13 2021-04-12 4 Schroeder Thilo PMVP Common Stock S - Sale I 33,1100 −100 −3 2 106 801
2021-04-13 2021-04-12 4 Schroeder Thilo PMVP Common Stock S - Sale I 32,0000 −900 −29 2 106 901
2021-04-13 2021-04-12 4 Schroeder Thilo PMVP Common Stock S - Sale I 31,1700 −2 903 −90 2 107 801
2021-04-13 2021-04-09 4 Schroeder Thilo PMVP Common Stock S - Sale I 34,8900 −19 858 −693 2 110 704
2021-04-13 2021-04-09 4 Schroeder Thilo PMVP Common Stock S - Sale I 33,7500 −5 905 −199 2 130 562
2021-04-08 2021-04-08 4 Schroeder Thilo PMVP Common Stock S - Sale I 34,2300 −20 701 −709 2 136 467
2021-04-08 2021-04-08 4 Schroeder Thilo PMVP Common Stock S - Sale I 33,8200 −12 621 −427 2 157 168
2021-04-08 2021-04-07 4 Schroeder Thilo PMVP Common Stock S - Sale I 34,5000 −100 −3 2 169 789
2021-04-08 2021-04-07 4 Schroeder Thilo PMVP Common Stock S - Sale I 33,8800 −24 357 −825 2 169 889
2021-04-08 2021-04-06 4 Schroeder Thilo PMVP Common Stock S - Sale I 34,6700 −67 086 −2 326 2 194 246
2021-04-08 2021-04-06 4 Schroeder Thilo PMVP Common Stock S - Sale I 33,8500 −11 571 −392 2 261 332
2021-04-08 2021-04-07 4 Alland Leila PMVP Employee Stock Option (right to buy) M - Exercise D 3,90 −4 000 373 850
2021-04-08 2021-04-07 4 Alland Leila PMVP Common Stock S - Sale D 34,4211 −28 −1 0
2021-04-08 2021-04-07 4 Alland Leila PMVP Common Stock S - Sale D 33,8572 −3 972 −134 28
2021-04-08 2021-04-07 4 Alland Leila PMVP Common Stock M - Exercise D 3,9000 4 000 16 4 000
2021-04-07 2021-04-05 4 BAUM CHARLES M PMVP Stock Option (right to buy) A - Award D 34,11 32 677 32 677
2021-04-05 2021-04-05 4 Schroeder Thilo PMVP Common Stock S - Sale I 34,0300 −29 203 −994 2 272 903
2021-04-05 2021-04-05 4 Schroeder Thilo PMVP Common Stock S - Sale I 33,4600 −18 990 −635 2 302 106
2021-04-05 2021-04-01 4 Schroeder Thilo PMVP Common Stock S - Sale I 32,9400 −12 435 −410 2 321 096
2021-03-31 2021-03-31 4 Schroeder Thilo PMVP Common Stock S - Sale I 32,9300 −13 645 −449 2 333 531
2021-03-31 2021-03-31 4 Schroeder Thilo PMVP Common Stock S - Sale I 32,3300 −18 381 −594 2 347 176
2021-03-31 2021-03-31 4 Schroeder Thilo PMVP Common Stock S - Sale I 31,1900 −1 600 −50 2 365 557
2021-03-31 2021-03-30 4 Schroeder Thilo PMVP Common Stock S - Sale I 31,1900 −3 276 −102 2 367 157
2021-03-31 2021-03-30 4 Schroeder Thilo PMVP Common Stock S - Sale I 30,8200 −19 207 −592 2 370 433
2021-03-31 2021-03-29 4 Schroeder Thilo PMVP Common Stock S - Sale I 33,1600 −764 −25 2 389 640
2021-03-31 2021-03-29 4 Schroeder Thilo PMVP Common Stock S - Sale I 31,6000 −1 410 −45 2 390 404
2021-03-26 2021-03-26 4 Schroeder Thilo PMVP Common Stock S - Sale I 33,4400 −35 268 −1 179 2 391 814
2021-03-26 2021-03-25 4 Schroeder Thilo PMVP Common Stock S - Sale I 34,8200 −1 200 −42 2 427 082
2021-03-26 2021-03-25 4 Schroeder Thilo PMVP Common Stock S - Sale I 34,1700 −3 787 −129 2 428 282
2021-03-26 2021-03-25 4 Schroeder Thilo PMVP Common Stock S - Sale I 32,9400 −61 340 −2 021 2 432 069
2021-03-26 2021-03-24 4 Schroeder Thilo PMVP Common Stock S - Sale I 39,0000 −10 100 −394 2 493 409
2021-03-26 2021-03-24 4 Schroeder Thilo PMVP Common Stock S - Sale I 37,5100 −700 −26 2 503 509
2021-03-26 2021-03-24 4 Schroeder Thilo PMVP Common Stock S - Sale I 36,5300 −5 079 −186 2 504 209
2021-03-26 2021-03-24 4 Schroeder Thilo PMVP Common Stock S - Sale I 35,1200 −19 002 −667 2 509 288
2021-03-25 2021-03-24 4 INTERWEST PARTNERS X LP By Gilbert H. Kliman PMVP Common Stock J - Other I 2 269 2 269
2021-03-25 2021-03-24 4 INTERWEST PARTNERS X LP By: Keval Desai PMVP Common Stock J - Other I 250 250
2021-03-25 2021-03-24 4 INTERWEST PARTNERS X LP By: Khaled A. Nasr PMVP Common Stock J - Other I 373 373
2021-03-25 2021-03-24 4 INTERWEST PARTNERS X LP By: InterWest Management Partners X, LLC PMVP Common Stock J - Other I −10 000 0
2021-03-25 2021-03-24 4 INTERWEST PARTNERS X LP By: InterWest Management Partners X, LLC PMVP Common Stock J - Other I 10 000 10 000
2021-03-25 2021-03-24 4 INTERWEST PARTNERS X LP PMVP Common Stock J - Other D −1 000 000 5 469 911
2020-12-31 2020-12-08 4 Kung Winston PMVP Stock Option (right to buy) M - Exercise D 3,22 −1 600 237 034
2020-12-31 2020-12-08 4 Kung Winston PMVP Common Stock M - Exercise D 3,2200 1 600 5 1 600
2020-11-20 2020-11-18 4 Mack David Henry PMVP Stock Option (right to buy) M - Exercise D 0,53 −2 470 492 867
2020-11-20 2020-11-18 4 Mack David Henry PMVP Common Stock M - Exercise D 0,5300 2 470 1 2 470
2020-11-12 2020-11-11 4 Heyman Richard A. PMVP Stock Option (right to buy) A - Award D 4,22 45 332 45 332
2020-10-02 2020-09-29 4/A INTERWEST PARTNERS X LP PMVP Series C Preferred Stock C - Conversion D −265 203 0
2020-10-02 2020-09-29 4/A INTERWEST PARTNERS X LP PMVP Series B Preferred Stock C - Conversion D −1 040 654 0
2020-10-02 2020-09-29 4/A INTERWEST PARTNERS X LP PMVP Series A Preferred Stock C - Conversion D −3 488 398 0
2020-10-02 2020-09-29 4/A INTERWEST PARTNERS X LP PMVP Series Seed Preferred Stock C - Conversion D −1 620 101 0
2020-10-02 2020-09-29 4/A INTERWEST PARTNERS X LP PMVP Common Stock C - Conversion D 265 203 6 469 911
2020-10-02 2020-09-29 4/A INTERWEST PARTNERS X LP PMVP Common Stock C - Conversion D 1 040 654 6 204 708
2020-10-02 2020-09-29 4/A INTERWEST PARTNERS X LP PMVP Common Stock C - Conversion D 3 488 398 5 164 054
2020-10-02 2020-09-29 4/A INTERWEST PARTNERS X LP PMVP Common Stock C - Conversion D 1 620 101 1 675 656
2020-10-02 2020-09-25 4/A INTERWEST PARTNERS X LP PMVP Common Stock P - Purchase D 18,0000 55 555 1 000 55 555
2020-10-02 2020-09-29 4/A ORONSKY ARNOLD L PMVP Series C Preferred Stock C - Conversion I −265 203 0
2020-10-02 2020-09-29 4/A ORONSKY ARNOLD L PMVP Series B Preferred Stock C - Conversion I −1 040 654 0
2020-10-02 2020-09-29 4/A ORONSKY ARNOLD L PMVP Series A Preferred Stock C - Conversion I −3 488 398 0
2020-10-02 2020-09-29 4/A ORONSKY ARNOLD L PMVP Series Seed Preferred Stock C - Conversion I −1 620 101 0
2020-10-02 2020-09-29 4/A ORONSKY ARNOLD L PMVP Common Stock C - Conversion I 265 203 6 469 911
2020-10-02 2020-09-29 4/A ORONSKY ARNOLD L PMVP Common Stock C - Conversion I 1 040 654 6 204 708
2020-10-02 2020-09-29 4/A ORONSKY ARNOLD L PMVP Common Stock C - Conversion I 3 488 398 5 164 054
2020-10-02 2020-09-29 4/A ORONSKY ARNOLD L PMVP Common Stock C - Conversion I 1 620 101 1 675 656
2020-10-02 2020-09-25 4/A ORONSKY ARNOLD L PMVP Common Stock P - Purchase I 18,0000 55 555 1 000 55 555
2020-09-29 2020-09-29 4 Nextech V Oncology S.C.S., SICAV-SIF PMVP Series D Preferred Stock C - Conversion D −760 267 0
2020-09-29 2020-09-29 4 Nextech V Oncology S.C.S., SICAV-SIF PMVP Series C Preferred Stock C - Conversion D −1 768 023 0
2020-09-29 2020-09-29 4 Nextech V Oncology S.C.S., SICAV-SIF PMVP Common Stock C - Conversion D 760 267 2 528 290
2020-09-29 2020-09-29 4 Nextech V Oncology S.C.S., SICAV-SIF PMVP Common Stock C - Conversion D 1 768 023 1 768 023
2020-09-29 2020-09-29 4 Euclidean Capital LLC PMVP Series C Preferred Stock C - Conversion I −132 601 0
2020-09-29 2020-09-29 4 Euclidean Capital LLC PMVP Series C Preferred Stock C - Conversion I −751 409 0
2020-09-29 2020-09-29 4 Euclidean Capital LLC PMVP Series B Preferred Stock C - Conversion I −2 601 637 0
2020-09-29 2020-09-29 4 Euclidean Capital LLC PMVP Series B Preferred Stock C - Conversion I −693 769 0
2020-09-29 2020-09-29 4 Euclidean Capital LLC PMVP Common Stock C - Conversion I 132 601 132 601
2020-09-29 2020-09-29 4 Euclidean Capital LLC PMVP Common Stock C - Conversion I 751 409 751 409
2020-09-29 2020-09-29 4 Euclidean Capital LLC PMVP Common Stock C - Conversion I 2 601 637 2 601 637
2020-09-29 2020-09-29 4 Euclidean Capital LLC PMVP Common Stock C - Conversion I 693 769 693 769
2020-09-29 2020-09-29 4 Wellington Biomedical Innovation Master Investors (Cayman) I L.P. PMVP Series D Preferred Stock C - Conversion D −760 267 0
2020-09-29 2020-09-29 4 Wellington Biomedical Innovation Master Investors (Cayman) I L.P. PMVP Common Stock C - Conversion D 760 267 760 267
2020-09-29 2020-09-29 4 ORBIMED ADVISORS LLC PMVP Series D Preferred Stock C - Conversion I −114 039 0
2020-09-29 2020-09-29 4 ORBIMED ADVISORS LLC PMVP Series D Preferred Stock C - Conversion I −380 133 0
2020-09-29 2020-09-29 4 ORBIMED ADVISORS LLC PMVP Series C Preferred Stock C - Conversion I −518 191 0
2020-09-29 2020-09-29 4 ORBIMED ADVISORS LLC PMVP Series B Preferred Stock C - Conversion I −1 076 891 0
2020-09-29 2020-09-29 4 ORBIMED ADVISORS LLC PMVP Series A Preferred Stock C - Conversion I −4 025 076 0
2020-09-29 2020-09-29 4 ORBIMED ADVISORS LLC PMVP Common Stock C - Conversion I 114 039 114 039
2020-09-29 2020-09-29 4 ORBIMED ADVISORS LLC PMVP Common Stock C - Conversion I 380 133 6 475 291
2020-09-29 2020-09-29 4 ORBIMED ADVISORS LLC PMVP Common Stock C - Conversion I 518 191 6 095 158
2020-09-29 2020-09-29 4 ORBIMED ADVISORS LLC PMVP Common Stock C - Conversion I 1 076 891 5 576 967
2020-09-29 2020-09-29 4 ORBIMED ADVISORS LLC PMVP Common Stock C - Conversion I 4 025 076 4 500 076
2020-09-29 2020-09-25 4 ORBIMED ADVISORS LLC PMVP Common Stock P - Purchase I 18,0000 475 000 8 550 475 000
2020-09-29 2020-09-25 4 ORBIMED ADVISORS LLC PMVP Common Stock P - Purchase I 18,0000 475 000 8 550 475 000
2020-09-29 2020-09-29 4 Boxer Capital, LLC PMVP Series D Preferred Stock C - Conversion I −28 129 0
2020-09-29 2020-09-29 4 Boxer Capital, LLC PMVP Series D Preferred Stock C - Conversion D −732 137 0
2020-09-29 2020-09-29 4 Boxer Capital, LLC PMVP Series C Preferred Stock C - Conversion I −32 708 0
2020-09-29 2020-09-29 4 Boxer Capital, LLC PMVP Series C Preferred Stock C - Conversion D −586 099 0
2020-09-29 2020-09-29 4 Boxer Capital, LLC PMVP Common Stock C - Conversion I 28 129 60 837
2020-09-29 2020-09-29 4 Boxer Capital, LLC PMVP Common Stock C - Conversion I 32 708 32 708
2020-09-29 2020-09-29 4 Boxer Capital, LLC PMVP Common Stock C - Conversion D 732 137 2 268 236
2020-09-29 2020-09-29 4 Boxer Capital, LLC PMVP Common Stock C - Conversion D 586 099 1 536 099
2020-09-29 2020-09-25 4 Boxer Capital, LLC PMVP Common Stock P - Purchase D 18,0000 950 000 17 100 950 000
2020-09-29 2020-09-29 4 Thompson Peter A. PMVP Series D Preferred Stock C - Conversion I −114 039 0
2020-09-29 2020-09-29 4 Thompson Peter A. PMVP Series D Preferred Stock C - Conversion I −380 133 0
2020-09-29 2020-09-29 4 Thompson Peter A. PMVP Series C Preferred Stock C - Conversion I −518 191 0
2020-09-29 2020-09-29 4 Thompson Peter A. PMVP Series B Preferred Stock C - Conversion I −1 076 891 0
2020-09-29 2020-09-29 4 Thompson Peter A. PMVP Series A Preferred Stock C - Conversion I −4 025 076 0
2020-09-29 2020-09-29 4 Thompson Peter A. PMVP Common Stock C - Conversion I 114 039 114 039
2020-09-29 2020-09-29 4 Thompson Peter A. PMVP Common Stock C - Conversion I 380 133 6 475 291
2020-09-29 2020-09-29 4 Thompson Peter A. PMVP Common Stock C - Conversion I 518 191 6 095 158
2020-09-29 2020-09-29 4 Thompson Peter A. PMVP Common Stock C - Conversion I 1 076 891 5 576 967
2020-09-29 2020-09-29 4 Thompson Peter A. PMVP Common Stock C - Conversion I 4 025 076 4 500 076
2020-09-29 2020-09-25 4 Thompson Peter A. PMVP Common Stock P - Purchase I 18,0000 475 000 8 550 475 000
2020-09-29 2020-09-25 4 Thompson Peter A. PMVP Common Stock P - Purchase I 18,0000 475 000 8 550 475 000
2020-09-29 2020-09-29 4 INTERWEST PARTNERS X LP PMVP Series C Preferred Stock C - Conversion D −265 203 0
2020-09-29 2020-09-29 4 INTERWEST PARTNERS X LP PMVP Series B Preferred Stock C - Conversion D −1 040 654 0
2020-09-29 2020-09-29 4 INTERWEST PARTNERS X LP PMVP Series A Preferred Stock C - Conversion D −3 488 398 0
2020-09-29 2020-09-29 4 INTERWEST PARTNERS X LP PMVP Series Seed Preferred Stock C - Conversion D −1 620 101 0
2020-09-29 2020-09-29 4 INTERWEST PARTNERS X LP PMVP Common Stock C - Conversion D 265 203 6 469 356
2020-09-29 2020-09-29 4 INTERWEST PARTNERS X LP PMVP Common Stock C - Conversion D 1 040 654 6 204 153
2020-09-29 2020-09-29 4 INTERWEST PARTNERS X LP PMVP Common Stock C - Conversion D 3 488 398 5 163 499
2020-09-29 2020-09-29 4 INTERWEST PARTNERS X LP PMVP Common Stock C - Conversion D 1 620 101 1 675 101
2020-09-29 2020-09-25 4 INTERWEST PARTNERS X LP PMVP Commonn Stock P - Purchase D 18,0000 55 000 990 55 000
2020-09-29 2020-09-29 4 Schroeder Thilo PMVP Series D Preferred Stock C - Conversion I −760 267 0
2020-09-29 2020-09-29 4 Schroeder Thilo PMVP Series C Preferred Stock C - Conversion I −1 768 023 0
2020-09-29 2020-09-29 4 Schroeder Thilo PMVP Common Stock C - Conversion I 760 267 2 528 290
2020-09-29 2020-09-29 4 Schroeder Thilo PMVP Common Stock C - Conversion I 1 768 023 1 768 023
2020-09-29 2020-09-29 4 ORONSKY ARNOLD L PMVP Series C Preferred Stock C - Conversion I −265 203 0
2020-09-29 2020-09-29 4 ORONSKY ARNOLD L PMVP Series B Preferred Stock C - Conversion I −1 040 654 0
2020-09-29 2020-09-29 4 ORONSKY ARNOLD L PMVP Series A Preferred Stock C - Conversion I −3 488 398 0
2020-09-29 2020-09-29 4 ORONSKY ARNOLD L PMVP Series Seed Preferred Stock C - Conversion I −1 620 101 0
2020-09-29 2020-09-29 4 ORONSKY ARNOLD L PMVP Common Stock C - Conversion I 265 203 6 469 356
2020-09-29 2020-09-29 4 ORONSKY ARNOLD L PMVP Common Stock C - Conversion I 1 040 654 6 204 153
2020-09-29 2020-09-29 4 ORONSKY ARNOLD L PMVP Common Stock C - Conversion I 3 488 398 5 163 499
2020-09-29 2020-09-29 4 ORONSKY ARNOLD L PMVP Common Stock C - Conversion I 1 620 101 1 675 101
2020-09-29 2020-09-25 4 ORONSKY ARNOLD L PMVP Common Stock P - Purchase I 18,0000 55 000 990 55 000
2020-09-29 2020-09-29 4 RA CAPITAL MANAGEMENT, LLC PMVP Series D Preferred Stock C - Conversion I −760 265 0
2020-09-29 2020-09-29 4 RA CAPITAL MANAGEMENT, LLC PMVP Common Stock P - Purchase I 18,0000 950 000 17 100 1 710 265
2020-09-29 2020-09-29 4 RA CAPITAL MANAGEMENT, LLC PMVP Common Stock C - Conversion I 760 265 760 265
2020-09-24 3 Double Epiphany, LLC PMVP Common Stock D 1 282 026
2020-09-24 3 Dawson Samantha PMVP Common Stock D 427 342
2020-09-24 3 Levine Alison PMVP Common Stock D 427 342
2020-09-24 3 LEVINE ARNOLD J PMVP Common Stock D 427 342
2020-09-24 3 Mack David Henry PMVP Common Stock I 227 915
2020-09-24 3 Mack David Henry PMVP Common Stock I 56 978
P
Köp på öppna marknaden eller privat köp av icke-derivatsäkerhet
S
Köp på öppna marknaden eller privat försäljning av icke-derivatsäkerhet
A
Bevilja, tilldelning eller annat förvärv av värdepapper från företaget (såsom en option)
C
Omvandling av derivat
D
Försäljning eller överföring av värdepapper tillbaka til företaget
F
Betalning av lösenpris eller skatteskuld med del av värdepapper som erhållits från bolaget
G
Överlåtelse av värdepapper från eller till insidern
K
Aktieswappar och liknande säkringsaffärer
M
Utövande eller omvandling av derivatsäkerhet som erhållits från företaget (som en option)
V
En transaktion friviligt rapporterad på schema 4
J
Andra (med en fotnot som beskriver transaktionen)
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista

© 2015-2025 Fintel Ventures LLC. All rights reserved. Fintel® is a registered trademark.

This website is provided “as is” without any representations or warranties, express or implied. Fintel makes no representations or warranties in relation to this website or the information and materials provided on this website. Nothing on this website constitutes, or is meant to constitute, advice of any kind. If you require advice in relation to any financial matter you should consult an appropriate professional.

About Fintel
Top Investors
Features
Explore
Help Center